Search results
ACIP recommends 3 doses (0, 1-2, 6 months) for people 10 years of age or older who are at increased risk 2†. ACIP* recommends 3 doses for persons who are at an increased risk of meningococcal disease or in a MenB outbreak situation.
Administer 2 or 3 doses. Administer 2 doses to healthy adolescents who are not at increased risk for serogroup B meningococcal disease. Administer the second dose 6 months after the first dose. Administer 3 doses to people 10 years of age or older who are at increased risk for meningococcal disease.
3 DOSAGE FORMS AND STRENGTHS. Trumenba is a suspension for intramuscular injection in 0.5 mL single-dose prefilled syringe.
24 paź 2024 · MenABCWY vaccine includes Trumenba ®. For subsequent doses after MenABCWY, administer: Trumenba ® for additional MenB dose(s) when MenACWY isn't indicated. Any MenACWY vaccine when MenB isn't indicated. Guidance for use as a booster dose. People with prolonged increased risk for serogroup A, C, W, or Y and B meningococcal disease need regular ...
Two-dose schedule: Administer a dose (0.5 mL) at 0 and 6 months. If the second dose is administered earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose. Three-dose schedule: Administer a dose (0.5 mL) at 0, 1–2, and 6 months.
Two-dose schedule: Administer a dose (0.5 mL) at 0 and 6 months. If the second dose is administered earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose.
Administer either Bexsero or Trumenba: Give 2 doses, 6 months apart. If dose #2 is given earlier than 6 months, give a third dose at least 4 months after dose #2.
